Wire Stories

Morse Micro Supercharges its Series B Funding Round with AU $30 Million Top-up from Major Superannuation Funds and Others

Telstra Super, Hesta, Hostplus, NGS, UniSuper and others bring total Series B funding to AU…

Guangzhou City Held the 132nd Canton Fair to Promote Trade Cooperation and Continue to Expand the “Circle of Friends” of China’s Foreign Trade

GUANGZHOU, China--(BUSINESS WIRE)--In 2022, the "cloud" terminal of the 132nd Canton Fair will be successfully…

Hibiki Path Advisors Sent Proposal Letters to Three Major Used Condominium Resalers

TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors (“Hibiki” or “We”), a value-oriented engagement investor, sent our formal letter…

Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients

China has the world’s largest iron deficiency anemia population with estimated prevalence of 15%1 Approval…

BLUETTI Is to Supercharge ISPO 2022

SHENZHEN, China--(BUSINESS WIRE)--#Bluetti--BLUETTI, a global leader in the clean energy storage industry, will present its…

MAP Selects Blue Yonder to Transform Planning Capabilities

Leading Indonesian lifestyle retailer to implement Blue Yonder’s Luminate Planning solutions to upgrade assortment, allocation…

2022 CHUNGBUK BEST PRODUCT PROMOTION Opens in Singapore to Develop Market for Promising Export Companies in Chungcheongbuk-do Province

32 Korean companies exhibit and sell their products in Jurong West Central, Singapore from November…

2022 CHUNGBUK BEST PRODUCT PROMOTION Opens in Singapore to Develop Market for Promising Export Companies in Chungcheongbuk-do Province

32 Korean companies exhibit and sell their products in Jurong West Central, Singapore from November…

Biocytogen Enters into Antibody Agreement with ADC Therapeutics

BEIJING--(BUSINESS WIRE)--#ADC--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announced that it has entered…

Biocytogen Enters into Antibody Agreement with ADC Therapeutics

BEIJING--(BUSINESS WIRE)--#ADC--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announced that it has entered…